Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 8, 2004, Pages 3872-3878

  Reilly, Muredach P ^a,d   Iqbal, Nayyar ^a,b   Schutta, Mark ^a,c   Wolfe, Megan L ^a   Scally, Monique ^a,c   Localio, A Russell ^a   Rader, Daniel J ^a   Kimmel, Stephen E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; VASCULAR DISEASE;

ADULT; AGED; CALCINOSIS; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED;

EID: 4043077647     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031676     Document Type: Article

References (56)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
2. Abate N 2000 Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14:154-174
3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT 2002 The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716
4. Ridker PM, Buring JE, Cook NR, Rifai N 2003 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107:391-397
5. Steppan CM, Lazar MA 2002 Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23
6. Rajala MW, Scherer PE 2003 Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773
7. Cooke JP, Oka RK 2002 Does leptin cause vascular disease? Circulation 106:1904-1905
8. Lyon CJ, Law RE, Hsueh WA 2003 Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144:2195-2200
9. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV 1996 Leptin: the tale of an obesity gene. Diabetes 45:1455-1462
10. Chu NF, Spiegelman D, Rifai N, Hotamisligil GS, Rimm EB 2000 Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord 24:1085-1092
11. Segal KR, Landt M, Klein S 1996 Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45:988-991
12. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG 1997 Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med 14:200-208
13. Zimmet PZ, Collins VR, de Courten MP, Hodge AM, Collier GR, Dowse GK, Alberti KG, Tuomilehto J, Hemraj F, Gareeboo H, Chitson P, Fareed D 1998 Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group. Int J Obes Relat Metab Disord 22:171-177
14. van Dielen FM, van't Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW 2001 Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 25:1759-1766
15. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M 2001 Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276:25096-25100
16. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY, Kim HS 2001 Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33:95-102
17. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL 2001 Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88:954-960
18. Santos-Alvarez J, Goberna R, Sanchez-Margalet V 1999 Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194:6-11
19. Faggioni R, Feingold KR, Grunfeld C 2001 Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 15:2565-2571
20. Kang SM, Kwon HM, Hong BK, Kim D, Kim IJ, Choi EY, Jang Y, Kim HS, Kim MS, Kwon HC 2000 Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. Yonsei Med J 41:68-75
21. Yen TT, Allan JA, Pearson DV, Schinitsky MR 1977 Dissociation of obesity, hypercholesterolemia and diabetes from atherosclerosis in ob/ob mice. Experientia 33:995-996
22. Hasty AH, Shimano H, Osuga J, Namatame I, Takahashi A, Yahagi N, Perrey S, Iizuka Y, Tamura Y, Amemiya-Kudo M, Yoshikawa T, Okazaki H, Ohashi K, Harada K, Matsuzaka T, Sone H, Gotoda T, Nagai R, Ishibashi S, Yamada N 2001 Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J Biol Chem 276:37402-37408
23. Bodary PF, Westrick RJ, Wickenheiser KJ, Shen Y, Eitzman DT 2002 Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 287:1706-1709
24. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N 2001 Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052-3056
25. Couillard C, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ, Despres JP 1998 Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 21:782-786
26. Ciccone M, Vettor R, Pannacciulli N, Minenna A, Bellacicco M, Rizzon P, Giorgino R, De Pergola G 2001 Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 25:805-810
27. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE 2003 Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157:25-31
28. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS 1995 Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92:2157-2162
29. Rumberger JA, Brundage BH, Rader DJ, Kondos G 1999 Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc [Erratum (1999) 74:538] 74:243-252
30. Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O'Donnell CJ 2002 Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes Care 25:1313-1319
31. Wolfe ML, Iqbal N, Gefter W, Mohler 3rd ER, Rader DJ, Reilly MP 2002 Coronary artery calcification at electron beam computed tomography is increased in asymptomatic type 2 diabetics independent of traditional risk factors. J Cardiovasc Risk 9:369-376
32. Hoff JA, Quinn L, Sevrukov A, Lipton RB, Daviglus M, Garside DB, Ajmere NK, Gandhi S, Kondos GT 2003 The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 41:1008-1012
33. Khaleeli E, Peters SR, Bobrowsky K, Oudiz RJ, Ko JY, Budoff MJ 2001 Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: implications for management. Am Heart J 141: 637-644
34. Hosoi M, Sato T, Yamagami K, Hasegawa T, Yamakita T, Miyamoto M, Yoshioka K, Yamamoto T, Ishii T, Tanaka S, Itoh A, Haze K, Fujii S 2002 Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients. Diabetes Care 25:696-701
35. Chu NF, Spiegelman D, Yu J, Rifai N, Hotamisligil GS, Rimm EB 2001 Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord 25:346-353
36. Hirany S, Li D, Jialal I 1997 A more valid measurement of low-density lipoprotein cholesterol in diabetic patients. Am J Med 102:48-53
37. Reilly MP, Wolfe ML, Localio AR, Rader DJ 2003 C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 23:1851-1856
38. Reilly MP, Wolfe ML, Localio AR, Rader DJ 2004 Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach. Atherosclerosis 173:69-78
39. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano R 1990 Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832
40. Wax Y 1992 Collinearity diagnosis for a relative risk regression analysis: an application to assessment of diet-cancer relationship in epidemiological studies. Stat Med 11:1273-1287
41. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM 2002 Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695-701
42. Newman AB, Naydeck BL, Whittle J, Sutton-Tyrrell K, Edmundowicz D, Kuller LH 2002 Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol 22:424-430
43. Fu V 1998 Estimating generalized ordered logit models. STATA Tech Bull 44:27-30
44. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caor JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
45. Bullo M, Garcia-Lorda P, Salas-Salvado J 2002 Plasma soluble tumor necrosis factor α receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol 146:325-331
46. Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL, Houmard JA, Marks RH, Caro JF 1996 Gender differences in serum leptin levels in humans. Biochem Mol Med 59:1-6
47. Considine RV 2001 Regulation of leptin production. Rev Endocr Metab Disord 2:357-363
48. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos GT 2001 Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol 87:1335-1339
49. Ioffe E, Moon B, Connolly E, Friedman JM 1998 Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci USA 95:11852-11857
50. Soderberg S, Olsson T, Eliasson M, Johnson O, Ahren B 1999 Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 245:533-543
51. O'Rourke L, Gronning LM, Yeaman SJ, Shepherd PR 2002 Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. J Biol Chem 277:42557-42562
52. Konstantinides S, Schafer K, Loskutoff DJ 2001 The prothrombotic effects of leptin: possible implications for the risk of cardiovascular disease in obesity. Ann NY Acad Sci 947:134-141; discussion 141-142
53. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T 1999 Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409-418
54. Soderberg S, Stegmayr B, Ahlbeck-Glader C, Slunga-Birgander L, Ahren B, Olsson T 2003 High leptin levels are associated with stroke. Cerebrovasc Dis 15:63-69
55. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G 2003 Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 26:2883-2889
56. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K 2003 Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 107:2571-2576